2011
DOI: 10.1007/s11999-011-1859-1
|View full text |Cite
|
Sign up to set email alerts
|

Breakout Session: Sex/Gender and Racial/Ethnic Disparities in the Care of Osteoporosis and Fragility Fractures

Abstract: Background Recent epidemiologic and clinical data suggest men and racial and ethnic minorities may receive lower-quality care for osteoporosis and fragility fractures than female and nonminority patients. The causes of such differences and optimal strategies for their reduction are unknown. Questions/purposes A panel was convened at the May

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…(128) This work highlights the need for greater and effective education strategies for providers on bone health and management strategies, particularly with a culturally relevant lens. (128) Initiatives by NOF and the American Orthopaedic Association (Bone ECHO) have incorporated more information for providers on racial differences in bone health, but more is needed, particularly at the primary care level, where osteoporosis is primarily managed.…”
Section: Healthcare Provider-level Strategiesmentioning
confidence: 99%
See 1 more Smart Citation
“…(128) This work highlights the need for greater and effective education strategies for providers on bone health and management strategies, particularly with a culturally relevant lens. (128) Initiatives by NOF and the American Orthopaedic Association (Bone ECHO) have incorporated more information for providers on racial differences in bone health, but more is needed, particularly at the primary care level, where osteoporosis is primarily managed.…”
Section: Healthcare Provider-level Strategiesmentioning
confidence: 99%
“…Healthcare providers' attitudes toward diagnosis and treatment of osteoporosis have been documented as major factors impacting recommendations for screening. ( 127 ) In a breakout session of the 2010 American Academy of Orthopaedic Surgeons/Orthopaedic Research Society/Association of Bone and Joint Surgeon Musculoskeletal Health Disparities Research Symposium, two of three factors identified that contribute to disparities in osteoporosis care among ethnic minority populations and men included: (i) “lack of awareness among healthcare providers and the public regarding the need for osteoporosis screening and prevention among non‐white and male patients, and (ii) “gaps in knowledge regarding the effectiveness of differing approaches to screening and medical management of osteoporosis, particularly among non‐white and male patients.” ( 128 ) This work highlights the need for greater and effective education strategies for providers on bone health and management strategies, particularly with a culturally relevant lens. ( 128 ) Initiatives by NOF and the American Orthopaedic Association (Bone ECHO) have incorporated more information for providers on racial differences in bone health, but more is needed, particularly at the primary care level, where osteoporosis is primarily managed.…”
Section: Strategies For Addressing Racial and Ethnic Bone Disparitiesmentioning
confidence: 99%
“…According to the World Health Organization (WHO), osteoporosis is diagnosed by measuring the bone mineral density (BMD) of the femoral neck using dual-energy X-ray absorption (DXA) [3] and is defined as BMD ≥ 2.5 standard deviations (SDs) below the average value of the young white female reference population (T-score ≤ −2.5), whereas low bone mass (or osteopenia) is defined as ≥1.0 SD but <2.5 SDs below the average value of the young white female reference population (−2.5 < T-score ≤ −1.0) [4]. Despite being the gold standard for osteoporosis diagnosis, DXA has not been adequately applied in osteoporosis screening because of its low availability, high cost [5], lack of public awareness of osteoporosis [6], lack of financial incentives to promote osteoporosis screening [7], and lack of DXA prescriptions [8].…”
Section: Introductionmentioning
confidence: 99%